---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-075191"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2023-03-21T23:59:59+00:00"
generated_at: "2026-06-17T22:23:52.761904+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# AVITA Medical appoints Cary Vance to Board of Directors, effective April 1, 2023

## Summary
- Cary Vance appointed as non-executive director, effective April 1, 2023, serving until 2023 Annual Meeting.
- Compensation: $70,000 annual cash, initial $210,000 stock grant (30% options, 70% RSUs), and $105,000 annual equity, subject to shareholder approval.
- Vance has over 25 years healthcare leadership, currently President/CEO of Titan Medical; prior roles include Hansen Medical, Covidien, and GE Healthcare.
- Board determined Vance meets independence standards; no material relationships or arrangements with the company.

## SEC filing metadata
- accession: 0001193125-23-075191
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2023-03-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000119312523075191/0001193125-23-075191-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000119312523075191/d467079d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-075191
- JSON: https://secwatch.observer/filing/0001193125-23-075191.json
- Plain text: https://secwatch.observer/filing/0001193125-23-075191.txt

## Key facts
- Executive change
  Cary Vance was appointed as Director at AVITA Medical, Inc..
  - Action: appointed
  - Role: Director
  source text: On March 16, 2023, AVITA Medical, Inc. (the “Company”) issued a press release announcing the appointment of Cary Vance to its Board of Directors (the “Board”), effective April 1, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312523075191/0001193125-23-075191-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.